NCT01632111
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University Hospital Zurich, Division of Internal Medicine Zurich, Switzerland
Clinical trial condition
Lipid Metabolism, Inborn Errors
Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.
841 public trials
150 recruiting studies
Lipid Metabolism, Inborn Errors trial results
NCT01439607
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
- Locations
-
- Bertrand Arnulf Paris, France
NCT02130505
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +19 more
- Locations
-
Not specified
NCT01388816
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Genova, Italy
- Milan, Italy
- Modena, Italy
- Palermo, Italy
NCT01747980
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
- Locations
-
- Rambam Medical Center Haifa, Israel
- Shaare Zedek Medical Center Jerusalem, Israel
Completed
Paricalcitol in Fabry Disease
NCT02090608
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
- Locations
-
- federico II university, department of nephrology Naples, Italy
Completed
Exploratory Study of Plaque Regression
NCT01515241
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Montreal Heart Institute Montreal, Quebec, Canada
NCT00655265
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
- Locations
-
- Service d'Endocrinologie, Metabolisme Prevention des Maladies Cardio-Vasculaires Paris, France
- Kardiologie Marburg, Germany
- Academic Medical Centre Amsterdam, Netherlands
- University Medical Centre Nijmegen, Netherlands
Completed
A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease
NCT02053896
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
- Locations
-
Not specified
NCT02048410
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia, Dyslipidemias, +10 more
- Locations
-
Not specified